Anti-Kaposi's sarcoma and antiangiogenic activities of sulfated dextrins

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 10, 1999, Pages 2528-2533

  Thornton, Mark ^a   Barkley, Laura ^a   Mason, Justin C ^a   Shaunak, Sunil ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR; DEXTRIN; DEXTRIN 2 SULFATE; DEXTRIN 6 SULFATE; POLYSACCHARIDE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOGENESIS; ANTIVIRAL ACTIVITY; ARTICLE; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSATE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNALIZATION; KAPOSI SARCOMA; PERITONEAL DIALYSIS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SULFATION;

EID: 0032820724     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.10.2528     Document Type: Article

References (37)

1. Bauer, J., M. Margolis, C. Schreiner, C.-J. Edgell, J. Azizkhan, E. Lazarowski, and R. L. Juliano. 1992. In vitro model of angiogenesis using a human endothelium derived permanent cell line: contributions of induced gene expression, G-proteins and integrins. J. Cell. Physiol. 153:437-449.
2. Biswas, D. K., B. J. Dezube, C. M. Ahlers, and A. B. Pardee. 1993. Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-kappa B action. J. Acquired Immune Defic. Syndr. 6:778-786.
3. Brown, K. J., S. F. Maynes, A. Bezos, D. J. Maguire, M. D. Ford, and C. R. Parish. 1996. A novel in vitro assay for human angiogenesis. Lab. Invest. 75:539-555.
4. Cejka, J. 1982. Enzyme immunoassay for factor VIII-related antigen. Clin. Chem. 28:1356-1358.
5. Cockerill, G. W., G. Meyer, L. Noack, M. A. Vadas, and J. R. Gamble. 1994. Characterization of a spontaneously transformed human endothelial cell line. Lab. Invest. 71:497-509.
6. Durieu, T. O., C. Federici, C. Creminon, C. N. Foignant, F. Roux, M. Claire, A. Strosberg, and P. O. Couraud. 1993. Nitric oxide and endothelin secretion by brain microvessel endothelial cells: regulation by cyclic nucleotides. J. Cell. Physiol. 155:104-111.
7. Folkman, J., R. Langer, R. J. Linhardt, C. Haudenschild, and S. Tayor. 1983. Angiogenesis inhibition and tumour regression caused by heparin or a heparin fragment in the presence of cortisone. Science 221:719-725.
8. Folks, T. M., J. Justement, A. Kinter, S. Schnittman, J. Orenstein, G. Poli, and A. S. Fauci. 1988. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J. Immunol. 140:1117-1122.
9. Hanahan, D., G. Christofori, P. Naik, and J. Arbeit. 1996. Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls and prospects for preclinical therapeutic models. Eur. J. Cancer 32A:2386-2393.
10. Jacobson, L. P., and H. K. Armenian. 1995. An integrated approach to the epidemiology of Kaposi's sarcoma. Curr. Opin. Oncol. 7:450-455.
11. Javan, C. M. 1997. Sulphated dextrins and primary isolates of HIV-1. Ph.D. thesis. University of London, London, United Kingdom.
12. Javan, C. M., N. J. Gooderham, R. J. Edwards, D. S. Davies, and S. Shaunak. 1997. Anti-HIV type-1 activity of sulphated derivatives of dextrin against primary viral isolates of HIV type 1 in lymphocytes and monocyte derived macrophages. AIDS Res. Hum. Retroviruses 13:875-880.
13. Kostianovsky, M., Y. Lamy, and M. A. Greco. 1992. Immunohistochemical and electron microscopic profiles of cutaneous Kaposi's sarcoma and bacillary angiomatosis. Ultrastruct. Pathol. 16:629-640.
14. Krown, S. E., C. Metroka, and J. C. Wernz. 1989. Kaposi's sarcoma in AIDS: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee. J. Clin. Oncol. 7:1201-1207.
15. Kubota, Y., H. K. Kleinman, G. R. Martin, and T. J. Lawley. 1988. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J. Cell. Biol. 107:1589-1598.
16. Lebbe, C., L. Blum, C. Pellet, G. Blanchard, O. Verola, P. Morel, O. Danne, and F. Calvo. 1998. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS 12:F45-F49.
17. Liaw, L., and S. M. Schwartz. 1993. Microtubule disruption stimulates DNA synthesis in bovine endothelial cells and potentiates cellular response to basic fibroblast growth factor. Am. J. Pathol. 143:937-948.
18. Lunardi-Iskandar, Y., P. Gill, V. H. Lam, R. A. Zeman, F. Michaels, D. L. Mann, M. S. Reitz, Jr., M. Kaplan, Z. N. Berneman, and D. Carter. 1995. Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma. J. Natl. Cancer Inst. 87:974-981.
19. Maddon, P. J., A. G. Dalgleish, J. S. McDougal, P. R. Clapham, R. A. Weiss, and R. Axel. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333-348.
20. Marin, L. A., C. E. Smith, M. Y. Langstem, D. Quashie, and L. E. Dillehay. 1991. Response of glioblastoma cell lines to low dose rate irradiation. Int. J. Radiat. Oncol. Biol. Phys. 21:397-402.
21. Morikawa, S., E. Tatsumi, M. Baba, T. Harada, and K. Yasuhira. 1978. Two E-rosette-forming lymphoid cell lines. Int. J. Cancer 21:166-170.
22. Murata, J., I. Saiki, T. Makabe, Y. Tsuta, S. Tokura, and T. Azuma. 1991. Inhibition of tumour-induced angiogenesis by sulfated chitin derivatives. Cancer Res. 51:22-26.
23. Nadji, M., A. R. Morales, J. Ziegles-Weissman, and N. S. Penneys. 1981. Kaposi's sarcoma: immunohistologic evidence for an endothelial origin. Arch. Pathol. Lab. Med. 105:274-275.
24. Nicosia, R. F., and A. Ottinetti. 1990. Growth of microvessels in serum-free matrix culture of rat aorta. Lab. Invest. 63:115-122.
25. Parums, D. V., J. L. Cordell, K. Micklem, A. R. Heryet, K. C. Gatter, and D. Y. Mason. 1990. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J. Clin. Pathol. 43:752-757.
26. Pluda, J. M., L. E. Shay, A. Foli, S. Tannenbaum, P. J. Cohen, B. R. Goldspiel, D. Adamo, M. R. Cooper, S. Broder, and R. Yarchoan. 1993. Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcoma. J. Nat. Cancer Inst. 85:1585-1592.
27. Popovic, M., M. G. Sarngadharan, E. Read, and R. C. Gallo. 1984. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497-500.
28. Requena, L., and O. P. Sangueza. 1998. Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms. J. Am. Acad. Dermatol. 38:143-175.
29. Risau, W. 1995. Differentiation of endothelium. FASEB J. 9:926-933.
30. Shaunak, S., N. J. Gooderham, R. J. Edwards, N. Payvandi, C. M. Javan, N. Baggett, J. MacDermot, J. N. Weber, and D. S. Davies. 1994. Infection by HIV-1 blocked by binding of dextrin 2-sulphate to the cell surface of activated human peripheral blood mononuclear cells and cultured T cells. Br. J. Pharmacol. 113:151-158.
31. Shaunak, S., M. Thornton, S. John, I. Teo, E. Peers, P. Mason, T. Krausz, and D. S. Davies. 1998. Reduction of the viral load of HIV-1 after the intraperitoneal administration of dextrin 2-sulphate in patients with AIDS. AIDS 12:399-409.
32. Sundstrom, C., and K. Nilsson. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17:565-577.
33. Tanaka, N. G., N. Sakamoto, K. Inoue, H. Korenaga, S. Kadoya, H. Ogawa, and Y. Osada. 1989. Antitumour effects of an antiangiogenic polysaccharide from an Arthrobactor species with or without a steriod. Cancer Res. 49:6727-6730.
34. Weiss, A., R. L. Wiskocil, and J. D. Stobo. 1984. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL-2 production reflects events occurring at a pre-translational level. J. Immunol. 133:123-128.
35. Wellicome, S. M., M. H. Thornhill, C. Pitzalis, D. S. Thomas, J. S. Lanchbury, G. S. Panayi, et al. 1990. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J. Immunol. 144:2558-2565.
36. Yoshida, A., A. B. Anand, and B. R. Zetter. 1996. Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors 13:57-64.
37. Zugmaier, G., M. E. Lippman, and A. Wellstein. 1992. Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumour cells and blockage by PPS of tumour growth in animals. J. Natl. Cancer Inst. 84:1716-1724.